Richard Evans

A new type of cholesterol drug in development by Amgen, Inc. (NASDAQ: AMGN) and another by Sanofi SA (ADR) (NYSE: SNY) with Regeneron Pharmaceuticals Inc (NASDAQ: REGN) may be "very expensive," according to a report in The Wall Street Journal. The new drugs are expected to be...

Chicago Fed president Richard Evans offers some good news on what is an otherwise dismal day in the financial markets. Mr. Evans told the Chicago Tribune editorial board he believes the U.S. economy could grow more rapidly in 2010 than current consensus forecasts. The expected growth rate of 3.5%...